Moderna said that sales of its COVID-19 shot in the third quarter came in at $4.8 billion, far less than the $5.8 billion expected by Wall Street analysts, according to a FactSet consensus.
It appears that Pfizer has taken the lead in the tug of war for market share among the leading COVID-19 vaccine makers, and Moderna’s investors aren’t happy about it.
Moderna said Thursday that sales of its COVID-19 shot in the third quarter came in at $4.8 billion, far less than the $5.8 billion expected by Wall Street analysts, according to a FactSet consensus. Pfizer has long had the first-mover advantage, getting the first broad authorization in the U.S. in December of last year. Later, Comirnaty became the only shot to receive full U.S. approval in individuals who are 16 years old and older and authorization in teens between the ages of 12 and 16 and children between the ages of 5 and 11 years old.That said, there may be some clinical differentiators.
“We see the sizable miss on vaccine sales as reflecting continued share loss to PFE,” SVB Leerink’s Mani Foroohar told investors on Thursday, citing global vaccine oversupply, loss of revenue among the adolescent and pediatric populations, and revisions to consensus expectations.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Moderna cuts 2021 sales forecast for COVID-19 vaccine; shares tumbleModerna Inc on Thursday cut its 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, as it struggles to ramp up production of its two-dose inoculation, sending its shares down 11% in premarket trading.
続きを読む »
Moderna Cuts Covid-19 Vaccine Sales Forecast for 2021Moderna's third-quarter earnings fell short of estimates as the pharmaceutical company lowered its sales outlook for the full year and said that some planned Covid-19 vaccine deliveries will slip into early 2022
続きを読む »
Los Angeles HS football team misses playoffs over COVID-19 vaccine mandateA high school football team in Los Angeles will be forced to miss the playoffs this year because not enough players are fully vaccinated, according to a report.
続きを読む »
At MetLife, Life Insurance Claims Rise for Younger People Dying From Covid-19Covid-19 cut into third-quarter results at MetLife as deaths linked to the Delta variant increased for people in their working years
続きを読む »
Merck Covid-19 Pill Cleared for Use in U.K., Its First AuthorizationU.K. health regulators cleared molnupiravir, becoming the first country to authorize the pill that can be taken at home and promises to keep people out of the hospital. The U.S. is expected to follow in coming months.
続きを読む »
Air Force says nearly 97% of active members complied with COVID-19 vaccine mandateThe Air Force said Wednesday that nearly 97% of its approximately 326,000 active duty service members have complied with Secretary of Defense Lloyd Austin's mandate and have received at least one dose of a coronavirus vaccine before the branch's Nov. 2 deadline.Why it matters: Around 8,500 active members missed the deadline. Many of them have filed for medical exemptions and religious accommodations, which are being reviewed by the department.Get market news worthy of your time with Axios Market
続きを読む »